China SXT Pharmaceuticals, Inc.
SXTC
$1.50
$0.021.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.24M | 18.24M | 18.51M | 18.51M | 12.07M |
| Total Receivables | 1.90M | 1.90M | 1.61M | 1.61M | 1.35M |
| Inventory | 1.13M | 1.13M | 1.59M | 1.59M | 809.80K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.40K | 30.40K | 276.50K | 276.50K | 6.80K |
| Total Current Assets | 21.30M | 21.30M | 21.99M | 21.99M | 14.23M |
|
|
|||||
| Total Current Assets | 21.30M | 21.30M | 21.99M | 21.99M | 14.23M |
| Net Property, Plant & Equipment | 355.20K | 355.20K | 443.20K | 443.20K | 564.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 11.80K | 11.80K | 15.90K | 15.90K | 19.10K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 8.55M | 8.55M | 8.31M |
| Total Assets | 21.66M | 21.66M | 31.00M | 31.00M | 23.13M |
|
|
|||||
| Total Accounts Payable | 1.16M | 1.16M | 1.66M | 1.66M | 1.28M |
| Total Accrued Expenses | 1.78M | 1.78M | 1.72M | 1.72M | 1.59M |
| Short-term Debt | 702.20K | 702.20K | 9.53M | 9.53M | 3.32M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 70.00K | 70.00K | 39.50K | 39.50K | 79.60K |
| Total Finance Division Other Current Liabilities | 2.30M | 2.30M | 2.71M | 2.71M | 2.63M |
| Total Other Current Liabilities | 2.30M | 2.30M | 2.71M | 2.71M | 2.63M |
| Total Current Liabilities | 6.01M | 6.01M | 15.66M | 15.66M | 8.90M |
|
|
|||||
| Total Current Liabilities | 6.01M | 6.01M | 15.66M | 15.66M | 8.90M |
| Long-Term Debt | 96.30K | 96.30K | 115.30K | 115.30K | 117.10K |
| Short-term Debt | 702.20K | 702.20K | 9.53M | 9.53M | 3.32M |
| Capital Leases | 115.40K | 115.40K | 182.70K | 182.70K | 177.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.22M | 6.22M | 15.96M | 15.96M | 9.20M |
|
|
|||||
| Common Stock & APIC | 44.53M | 44.53M | 41.12M | 41.12M | 39.67M |
| Retained Earnings | -28.02M | -28.02M | -25.51M | -25.51M | -24.71M |
| Treasury Stock & Other | -1.08M | -1.08M | -568.90K | -568.90K | -1.03M |
| Total Common Equity | 15.44M | 15.44M | 15.04M | 15.04M | 13.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.44M | 15.44M | 15.04M | 15.04M | 13.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.44M | 15.44M | 15.04M | 15.04M | 13.93M |
|
|
|||||